✦ LIBER ✦

Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment

✍ Scribed by José M. Sánchez–Tapias; Moisés Diago; Pedro Escartín; Jaime Enríquez; Manuel Romero–Gómez; Rafael Bárcena; Javier Crespo; Raúl Andrade; Eva Martínez–Bauer; Ramón Pérez; Milagros Testillano; Ramón Planas; Ricard Solá; Manuel García–Bengoechea; Javier Garcia–Samaniego; Miguel Muñoz–Sánchez; Ricardo Moreno–Otero

Book ID: 119759305
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 299 KB
Volume: 131
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2006.05.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extended Treatment Duration for Hepatiti

Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin

✍ Thomas Berg; Michael von Wagner; Samer Nasser; Christoph Sarrazin; Tobias Heintg 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Peginterferon Alfa-2a/Ribavirin for 48 o

Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response

✍ Peter Ferenci; Hermann Laferl; Thomas–Matthias Scherzer; Andreas Maieron; Harald 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 1020 KB

Cochrane Database of Systematic Reviews

Cochrane Database of Systematic Reviews (Reviews) || Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients

✍ Katz, Lior H 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 656 KB

808 ASSESSMENT OF VIROLOGICAL RESPONSE A

808 ASSESSMENT OF VIROLOGICAL RESPONSE AT BOTH WEEK 4 AND WEEK 12 OPTIMIZES PREDICTION OF PEGINTERFERON ALFA PLUS RIBAVIRIN.TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

✍ M. Martinot-Peignoux; M.P. Ripault; R. Moucari; N. Boyer; S. Maylin; A.C. Cardos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Randomized trial of peginterferon alfa-2

Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virological response

✍ Brian L. Pearlman; Carole Ehleben 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 2 views

Randomized trial of peginterferon alfa-2

Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response

✍ Maria Buti; Yoav Lurie; Natalia G. Zakharova; Natalia P. Blokhina; Andrzej Horba 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 2 views

The benefit of extending treatment duration with peginterferon (PEG-IFN) and ribavirin (RBV) from 48 weeks to 72 weeks for patients with chronic hepatitis C genotype 1 infection has not been well established. In this prospective, international, open-label, randomized, multicenter study, 1,428 treatm